Objectives: To characterize, phenotypically and genotypically, the first Enterococcus faecium clinical isolate harbouring a vanG operon.
Introduction
Despite being commensal bacteria of the human gut microbiota, enterococci have become major opportunistic pathogens. 1 In addition, vancomycin-resistant Enterococcus faecium (VREF) is currently a member of the list of bacteria, recently edited by the WHO, for which new antibiotics are urgently needed (http:// www.who.int/mediacentre/news/releases/2017/bacteria-antibi otics-needed/en/). This points to the worldwide emergence of this species, especially hospital-adapted strains belonging to clonal complex (CC) 17, that leads to major concerns in clinical settings. 2 Glycopeptide resistance is due to the presence of van operons that encode enzymes catalysing the production of modified peptidoglycan precursors ending in D-Ala-D-Lac (VanA, B, D and M) or D-Ala-D-Ser (VanC, E, G, L and N). 2 These precursors have much less affinity for vancomycin than the D-Ala-D-Ala motif, leading to a resistant phenotype (MIC of vancomycin .4 mg/L). 2 Moreover, these operons are tightly regulated by a VanS/VanR-type two-component system, where VanS is a membrane-bound histidine kinase and VanR is a transcriptional regulator. 3 Because some van operons are part of mobile genetic elements, the glycopeptide resistance has spread among enterococci.
The vanG operon, in which the VanG ligase allows synthesis of a precursor ending in D-Ala-D-Ser, has only been detected in a few Enterococcus faecalis clinical isolates and confers moderate levels of resistance to vancomycin (MIC 16 mg/L), but not to teicoplanin. 4, 5 It is characterized by a 'three-component' regulatory system that includes an additional repressor (VanU G ) also involved in the control of the vanG operon transcription. 6 We report, to the best of our knowledge, the first clinical isolate of E. faecium harbouring a vanG operon. The genome of this strain (E. faecium 16-346) was completely sequenced and we identified in the chromosome an acquired putative mobile genetic element containing the vanG locus. E. faecium BM4107 and E. faecalis JH2-2 were used for filter mating experiments.
MICs of 20 antibiotics (chloramphenicol, daptomycin, gentamicin, linezolid, rifampicin, trimethoprim/sulfamethoxazole, quinupristin/dalfopristin, tetracycline, erythromycin, oxacillin, ampicillin, penicillin G, vancomycin, levofloxacin, tigecycline, moxifloxacin, clindamycin, streptomycin, ciprofloxacin and nitrofurantoin) were determined using a Sensititre TM automated system (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions.
WGS and accession number
The whole genome sequence of the E. faecium 16-346 strain was determined with PacBio technology (GATC Biotech, Konstanz, Germany). The sequence was annotated using the NCBI Prokaryotic Genome Annotation Pipeline. 7 The sequence was submitted to GenBank and assigned accession number CP021849.
Filter mating
Transfer of vancomycin resistance from E. faecium 16-346 to E. faecium BM4107 and E. faecalis JH2-2 was attempted by filter mating. Transconjugants were selected on brain heart infusion (BHI) agar containing rifampicin (60 mg/L), fusidic acid (50 mg/L) and vancomycin (4 mg/L).
Reverse-transcription quantitative PCR (RT-qPCR) experiments
The expression of the vanG gene was assessed by RT-qPCR using RNA extracted from bacterial cells (OD 600 of 0.5) grown in the absence or in the presence of subinhibitory concentrations of vancomycin (i.e. 1 or 2 mg/L). PCR amplification was carried out with primers specific for vanG (vanG-F: 5 0 -TTCGTGCAGGCTCTTCCTTT-3 0 ; vanG-R: 5 0 -CACAACCGACTTCAAAGCCG-3 0 ) or adk (housekeeping reference gene) as described previously. 8 
Results and discussion
Characterization of E. faecium E. faecium 16-346 was resistant to vancomycin (MIC 8 mg/L). It was also resistant to rifampicin (MIC .4 mg/L), erythromycin (MIC .4 mg/L) and tetracycline (MIC .16 mg/L), but remained susceptible to teicoplanin (MIC 0.5 mg/L) and to the other antibiotics tested. Screening by specific PCR for the presence of the vanA, vanB, vanD, vanM and vanN genes, known to confer glycopeptide resistance in this species, was negative.
2 Primers specific for the other van operons not yet described in E. faecium were tested and an amplification of the vanG gene was obtained. vanG-type operons have only been found in E. faecalis clinical isolates from Australia and Canada, as well as in various Clostridium spp. 4, 5, 9, 10 In the latter, vanG did not confer vancomycin resistance, but they may, however, be considered as a possible reservoir. It has been shown that part of the microflora of the human gastrointestinal tract harbours the vanG gene. 11 Indeed, from 248 rectal swab samples, Domingo et al. 12 showed that 9.3% were positive for vanG, but none was associated with enterococci. Since, to our knowledge, no VanG-type E. faecium have been identified so far, we further analysed this strain by WGS.
With a size of 2 736 595 bp, the genome harboured 2824 putative genes (2730 coding sequences) ( Figure S1 , available as Supplementary data at JAC Online). This strain was plasmid free and belonged to ST121. Search for resistance genes revealed the presence of the vanG operon, but also that of erm(Y) and msr(C), both involved in macrolide resistance, as well as that of tet(M) and tet(L) that confer tetracycline resistance (Table 1) . These data were in agreement with the resistance phenotype of E. faecium 16-346.
Analysis of the vanG operon
The sequence of the vanG operon was very similar to those from E. faecalis BM4518, WCH9 and G1-0247 (Figure 1) . 4, 5, 13 Indeed, the van genes (U G , R G , S G , Y G , W G , G, XY G and T G ) were between 99.82% and 100% identical (Table 1) . Thus, after VanN, VanG is the second ligase able to synthesize D-Ala-D-Ser-ending precursors in E. faecium.
14 This is consistent with low-level vancomycin resistance (MIC 8-16 mg/L), since the precursors ending with D-Ala-DSer present only a 7-fold lower affinity for the antibiotic. 15 In vanY G of E. faecalis BM4518, a frameshift mutation is present. 13 In E. faecium, vanY G has no mutations, as in the vanY G from E. faecalis G1-0247 strain. 5 Twenty-two bp imperfect IRs framed the mobile genetic element (Figure 1) . In E. faecalis BM4518, the element is 240 kb long, whereas, in E. faecium, its size was 45.5 kb comprising 43 genes (Table S1 ). Of note, the sequence of the left IR was identical to that of E. faecalis G1-0247 (CGGTAGTACTTCTTTCCCACAA) and diverged from that of BM4518 by 2 bases (CGGTGGTACTGCTTTCCCACAA). 5, 13 Surprisingly, the sequence of the left DR (TGGA) was not the same as the TTGA sequence of the right DR (Figure 1) . Based on the sequence of the reference strain E. faecium AUS 0004, TGGA appears as the motif present in the gene in which the element has been inserted. 16 It may be hypothesized that the target site of integration could be only the GA 2 bp sequence. To date, in E. faecalis, two types of vanG operon have been characterized, one from strains BM4518, WCH9 and G1-0247 (vanG) and another from N03-0233 (vanG2), lacking the vanY G gene and showing also a 2 bp (CA) DR. 5 Interestingly, in all the VanG-type strains (clinical isolates or transconjugants) insertion of the vanG cluster systematically occurred in the gene encoding an RNA methyltransferase, whereas vanG2 is located in the dctP gene (encoding a subunit of the TRAP dicarboxylate transporter). 13 This was not observed in E. faecium where the element was integrated in a gene encoding a hypothetical protein (annotated EFAU004_00391) (Figure 1 ).
Attempts to transfer and inducibility of expression of the vanG operon
We were unable to transfer vancomycin resistance from E. faecium 16-346 to E. faecium BM4107 and E. faecalis JH2-2. Similarly, McKessar et al. 4 failed to transfer vanG operons from E. faecalis to E. faecium. In E. faecalis BM4518, erm(B) was co-transferred with vanG and transconjugants could only be obtained on erythromycin-containing plates. 13 In E. faecium 16-346, the mobile genetic element did not harbour erm(B) and macrolide resistance was likely due to the presence of the erm(Y) and msr(C)
VanG-type vancomycin-resistant E. faecium JAC genes located 231 and 522 kb downstream, respectively ( Table 1) . As in E. faecalis G1-0247 and N03-0233, it may be possible that the experimental conditions were not adapted.
In order to test if vanG expression was inducible, RT-qPCR experiments were carried out from cells grown with 0, 1 or 2 mg/L vancomycin (1 and 2 mg/L vancomycin corresponding to 1 = 8 and 1 = 4 of MIC, respectively). As expected, vanG transcription was increased 3-and 5-fold (P , 0.05) in the presence of 1 and 2 mg/L antibiotic, respectively. This strongly suggests that transcriptional regulation may be similar to that of E. faecalis where the repressor VanU G and the activator VanR G (both present in E. faecium) compete for the same P YG promoter leading to rheostatic control of vanG operon expression. 6 
Conclusions
To our knowledge, this is the first report of a vanG-type locus acquired by a strain of E. faecium. This points out that the surveillance of VREF remains crucial to overcome the spread of this major opportunistic pathogen. 
